Current Perspectives on Echinocandin Class Drugs

Cited by (276)

Items 101–200 of 276

1. Microcolony Imaging of Aspergillus fumigatus Treated with Echinocandins Reveals Both Fungistatic and Fungicidal Activities
   Colin J. Ingham, Peter M. Schneeberger · 2012 · PLoS ONE
2. CD101, a novel echinocandin, possesses potent antibiofilm activity against early and mature Candida albicans biofilms
   Chandra, Jyotsna, Ghannoum, Mahmoud A. · 2018 · Antimicrobial Agents and Chemotherapy
3. An insight into new strategies to combat antifungal drug resistance
   Yanhua Zheng, Yueyun Ma, Yi Ding, Xiequn Chen, Guangxun Gao · 2018 · Drug Design Development and Therapy
4. Critical Assessment of Cell Wall Integrity Factors Contributing to in vivo Echinocandin Tolerance and Resistance in Candida glabrata
   Garcia-Rubio, Rocio, Hernandez, Rosa Y., Clear, Alissa, Healey, Kelley R., Shor, Erika, Perlin, David S. · 2021 · Frontiers in Microbiology
5. Phytochemicals and Their Antifungal Potential against Pathogenic Yeasts
   Cristina de Andrade Monteiro, Julliana Ribeiro Alves dos Santos · 2019 · IntechOpen eBooks
6. Fluconazole and Lipopeptide Surfactin Interplay During Candida albicans Plasma Membrane and Cell Wall Remodeling Increases Fungal Immune System Exposure
   Jakub Suchodolski, Daria Derkacz, Jakub Muraszko, Jarosław Jan Panek, Aneta Jezierska, Marcin Łukaszewicz, Anna Krasowska · 2020 · Pharmaceutics
7. How urgent is the need for new antifungals?
   Adam G. Stewart, David L. Paterson · 2021 · Expert Opinion on Pharmacotherapy
8. Persistence and drug tolerance in pathogenic yeast
   Rasmus K. Bojsen, Birgitte Regenberg, Anders Folkesson · 2016 · Current Genetics
9. Enhancing Molecular Approaches for Diagnosis of Fungal Infections
   Sean X. Zhang · 2013 · Future Microbiology
10. Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin
    James M. Apgar, Robert R. Wilkening, Mark L. Greenlee, James M. Balkovec, Amy M. Flattery, George K. Abruzzo, Andrew M. Galgoci, ROBERT A. GIACOBBE, Charles Gill, Ming Jo Hsu et al. · 2015 · Bioorganic & Medicinal Chemistry Letters
11. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods
    Maria Teresa Montagna, Grazia Lovero, Caterina Coretti, Domenico Martinelli, Osvalda De Giglio, Roberta Iatta, Stella Balbino, Antonio Rosato, Giuseppina Caggiano · 2015 · BMC Microbiology
12. AFM combined to ATR-FTIR reveals Candida cell wall changes under caspofungin treatment
    Fabienne Quilès, Isabelle Accoceberry, Célia Couzigou, Grégory Francius, Thierry Noël, Sofiane El‐Kirat‐Chatel · 2017 · Nanoscale
13. Biocatalytic Synthesis of Fungal β-Glucans
    Lefki‐Maria Papaspyridi, Anastasia Zerva, Evangelos Topakas · 2018 · Catalysts
14. Jatrophanes from Euphorbia squamosa as Potent Inhibitors of Candida albicans Multidrug Transporters
    Manpreet Kaur Rawal, Yalda Shokoohinia, Giuseppina Chianese, Behzad Zolfaghari, Giovanni Appendino, Orazio Taglialatela‐Scafati, Rajendra Prasad, Attilio Di Pietro · 2014 · Journal of Natural Products
15. Candida Efflux ATPases and Antiporters in Clinical Drug Resistance
    Prasad, Rajendra, Rawal, Manpreet Kaur, Shah, Abdul Haseeb · 2016 · Advances in Experimental Medicine and Biology
16. Meyerozyma guilliermondii species complex: review of current epidemiology, antifungal resistance, and mechanisms
    Reza Ghasemi, Ensieh Lotfali, Kamran Rezaei, Seyed Ataollah Madinehzad, Mahdi Falah Tafti, Nikta Aliabadi, Ebrahim Kouhsari, Azam Fattahi · 2022 · Brazilian Journal of Microbiology
17. Ultrashort Self-Assembling Peptide Hydrogel for the Treatment of Fungal Infections
    Alyaa A. Albadr, Sophie M. Coulter, Simon L. Porter, Raghu Raj Singh Thakur, Garry Laverty · 2018 · Gels
18. Multifactorial Role of Mitochondria in Echinocandin Tolerance Revealed by Transcriptome Analysis of Drug-Tolerant Cells
    Garcia-Rubio, Rocio, Jimenez-Ortigosa, Cristina, DeGregorio, Lucius, Quinteros, Christopher, Shor, Erika, Perlin, David S. · 2021 · mBio
19. Role of FKS Gene in the Susceptibility of Pathogenic Fungi to Echinocandins
    Yasuhiro Hori, Kazutoshi Shibuya · 2018 · Medical Mycology Journal
20. Epidemiology of Echinocandin Resistance in Candida
    Nina T. Grossman, Tom M Chiller, Shawn R. Lockhart · 2014 · Current Fungal Infection Reports
21. Promising immunotherapeutic targets for treating candidiasis
    Zhe Chuan Feng, Hui Lu, Yuanying Jiang · 2024 · Frontiers in Cellular and Infection Microbiology
22. Caspofungin-induced β(1,3)-glucan exposure in Candida albicans is driven by increased chitin levels
    Wagner, Andrew S., Lumsdaine, Stephen W., Mangrum, Mikayla M., Reynolds, Todd B. · 2023 · mBio
23. Reshaping Echinocandin Antifungal Drugs To Circumvent Glucan Synthase Point‐Mutation‐Mediated Resistance
    Moriah Jospe‐Kaufman, Efrat Ben‐Zeev, Austin Mottola, Anna Dukhovny, Judith G. Berman, Shmuel Carmeli, Micha Fridman · 2023 · Angewandte Chemie International Edition
24. The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics
    David R. Andes, Roger J. M. Brüggemann, Shawn Flanagan, Alexander J. Lepak, Russell Edward Lewis, Voon S. Ong, Christopher M. Rubino, Taylor Sandison · 2024 · Journal of Antimicrobial Chemotherapy
25. New perspectives on the topical management of recurrent candidiasis
    Ana Carolina dos Santos Ré, Jayanaraian F. Martins, Marcilio Cunha Filho, Guilherme M. Gelfuso, Carolina Patrícia Aires, Taís Gratieri · 2021 · Drug Delivery and Translational Research
26. Sbg1 Is a Novel Regulator for the Localization of the β-Glucan Synthase Bgs1 in Fission Yeast
    Reshma Davidson, Josef Pontasch, Jian‐Qiu Wu · 2016 · PLoS ONE
27. Comparative Analysis of Polysaccharide and Cell Wall Structure in Aspergillus nidulans and Aspergillus fumigatus by Solid-State NMR
    Isha Gautam, Jayasubba Reddy Yarava, Yifan Xu, Reina Li, Faith J. Scott, Frédéric Mentink‐Vigier, Michelle Momany, Jean‐Paul Latgé, Tuo Wang · 2024 · Carbohydrate Polymers
28. Role of Innate Immune Receptors in Paradoxical Caspofungin ActivityIn Vivoin Preclinical Aspergillosis
    Silvia Moretti, Silvia Bozza, Carmen D'Angelo, Andrea Casagrande, Maria Agnese Della Fazia, Lucia Pitzurra, Luigina R. Romani, Franco Aversa · 2012 · Antimicrobial Agents and Chemotherapy
29. Antifungal Drugs: Mechanism of Action and Resistance
    Muhammad Zeeshan Ahmed, Tazeen Rao, Ali Saeed, Zeeshan Mutahir, Shahzeb Hameed, Samrana Inayat, Haseeba Shahzad, Najeeb Ullah, Muhammad Abaid-Ullah, Muhammad Ibrahim et al. · 2021 · Springer eBooks
30. Recent progress on anti-Candida natural products
    Fu–Juan Sun, Min Li, Liang GU, Mingling Wang, Ming‐Hua Yang · 2021 · Chinese Journal of Natural Medicines
31. Scanning Quadrupole Data-Independent Acquisition, Part B: Application to the Analysis of the Calcineurin-Interacting Proteins during Treatment of Aspergillus fumigatus with Azole and Echinocandin Antifungal Drugs
    Praveen R. Juvvadi, Martin Arthur Moseley, Christopher J. Hughes, Erik J. Soderblom, Sarah Lennon, Simon R. Perkins, J. Will Thompson, Scott J. Geromanos, Jason L. Wildgoose, Keith Richardson et al. · 2017 · Journal of Proteome Research
32. Benzylic Dehydroxylation of Echinocandin Antifungal Drugs Restores Efficacy against Resistance Conferred by Mutated Glucan Synthase
    Dana Logviniuk, Qais Z. Jaber, Roman Dobrovetsky, Noga Kozer, Ewa Księżopolska, Toni Gabaldón, Shmuel Carmeli, Micha Fridman · 2022 · Journal of the American Chemical Society
33. In vitro potency and fungicidal activity of CD101, a novel echinocandin, against recent clinical isolates of Candida spp.
    Danielle Hall, Robert Bonifas, Laure Stapert, Mary Thwaites, Dean L. Shinabarger, Chris M. Pillar · 2017 · Diagnostic Microbiology and Infectious Disease
34. Micafungin Enhances the Human Macrophage Response to Candida albicans through β-Glucan Exposure
    José Pedro Guirao-Abad, Ruth Sánchez-Fresneda, Francisco Machado, Juan Carlos Argüelles, María Martinez‐Esparza · 2018 · Antimicrobial Agents and Chemotherapy
35. Antifungal peptides: Therapeutic potential and challenges before their commercial success
    Anindita Sharma, Gursharan Singh, Jasvinder Singh Bhatti, Simarpreet Kaur Gill, Shailendra Kumar Arya · 2024 · International Journal of Biological Macromolecules
36. Discovery of Novel 8-Hydroxyquinoline Derivatives with Potent In Vitro and In Vivo Antifungal Activity
    Liping Li, Hao Wu, Jiayin Wang, Zhe Ji, Ting Fang, Hui Lu, Lan Yan, Fu‐Ming Shen, Dazhi Zhang, Yuanying Jiang et al. · 2023 · Journal of Medicinal Chemistry
37. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains
    Laura Bedin Denardi, Jéssica Tairine Keller, Vanessa Oliveira, Débora Alves Nunes Mario, Jânio Morais Santúrio, Sydney Hartz Alves · 2017 · Mycopathologia
38. Comparison of Dimethyl Sulfoxide and Water as Solvents for Echinocandin Susceptibility Testing by the EUCAST Methodology
    Ana Alastruey‐Izquierdo, Alicia Gómez‐López, Maiken Cavling Arendrup, Cornelia Lass‐Flörl, William W. Hope, David S. Perlin, Juan L. Rodrı́guez-Tudela, Manuel Cuenca‐Estrella · 2012 · Journal of Clinical Microbiology
39. Echinocandin-Resistant Candida: Molecular Methods and Phenotypes
    David S. Perlin · 2011 · Current Fungal Infection Reports
40. A novel, tomographic imaging probe for rapid diagnosis of fungal keratitis
    Min Hee Lee, Gregory R. Wiedman, Steven Park, Arkady A. MUSTAEV, Yanan Zhao, David S. Perlin · 2017 · Medical Mycology
41. Evaluation of fungal-specific fluorescent labeled echinocandin probes as diagnostic adjuncts
    Ayiasha Pratt, Guillermo García‐Effrón, Yanan Zhao, Steven Park, Arkady A. MUSTAEV, Shyamala Pillai, David S. Perlin · 2012 · Medical Mycology
42. In Vitro Selection of Thioether-Closed Macrocyclic Peptide Ligands by Means of the RaPID System
    Takayuki Katoh, Yuki Goto, Hiroaki Suga · 2021 · Methods in molecular biology
43. Efg1 and Cas5 Orchestrate Cell Wall Damage Response to Caspofungin in Candida albicans
    Kang Xiong, Chang Su, Qiangqiang Sun, Yang Lü · 2020 · Antimicrobial Agents and Chemotherapy
44. The impact of antifungals on toll-like receptors
    Mircea Radu Mihu, Rodney Pattabhi, Joshua Daniel Nosanchuk · 2014 · Frontiers in Microbiology
45. Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression
    Kyoko Niimi, Matthew A. Woods, Katsuyuki Maki, Hironobu Nakayama, Kazuaki Hatakenaka, Hiroji Chibana, Fumiaki Ikeda, Keigo Ueno, Masakazu Niimi, Richard David Cannon et al. · 2012 · Journal of Antimicrobial Chemotherapy
46. Target Enzyme Mutations Confer Differential Echinocandin Susceptibilities in Candida kefyr
    Janet F. Staab, Dionysios Neofytos, Peter Rhee, Cristina Jiménez‐Ortigosa, Sean X. Zhang, David S. Perlin, Kieren A. Marr · 2014 · Antimicrobial Agents and Chemotherapy
47. Synthesis of new piperazinyl-pyrrolo[1,2- a ]quinoxaline derivatives as inhibitors of Candida albicans multidrug transporters by a Buchwald–Hartwig cross-coupling reaction
    Jean Guillon, Shweta Nim, Stéphane Moreau, Luisa Ronga, Solène Savrimoutou, Elisabeth Thivet, Mathieu Marchivie, Attilio Di Pietro, Rajendra Prasad, Marc Le Borgne · 2020 · RSC Advances
48. A Review on Molecular Mechanisms of Antifungal Resistance in Candida glabrata : Update and Recent Advances
    Ensieh Lotfali, Azam Fattahi, Shirin Sayyahfar, Reza Ghasemi, Mohammad Mahdi Rabiei, Mobina Fathi, Kimia Ghazi Vakili, Niloofar Deravi, Amirali Soheili, Hossein Toreyhi et al. · 2021 · Microbial Drug Resistance
49. Time-Kill Kinetics of Rezafungin (CD101) in Vagina-Simulative Medium for Fluconazole-Susceptible and Fluconazole-ResistantCandida albicansand Non-albicans CandidaSpecies
    Jeffrey B. Locke, Amanda L. Almaguer, Joanna L. Donatelli, Ken F. Bartizal · 2018 · Infectious Diseases in Obstetrics and Gynecology
50. Two Sequential Clinical Isolates of Candida glabrata with Multidrug-Resistance to Posaconazole and Echinocandins
    Qiqi Wang, Yun Li, Xuan Cai, Ruoyu Li, Bo Zheng, Ence Yang, Tianyu Liang, Xinyu Yang, Zhe Wan, Wei Liu · 2021 · Antibiotics
51. New Vision of Cell Walls in Aspergillus fumigatus from Solid-State NMR Spectroscopy
    Isha Gautam, Kalpana Singh, Malitha C. Dickwella Widanage, Jayasubba Reddy Yarava, Tuo Wang · 2024 · Journal of Fungi
52. Progress in the Stereoselective Synthesis Methods of Pyrrolidine-Containing Drugs and Their Precursors
    Аndrey V. Smolobochkin, Almir Sabirovich Gazizov, Nurbol Orynbasaruly Appazov, Oleg Gerol'dovich Sinyashin, Alexander Romanovich Burilov · 2024 · International Journal of Molecular Sciences
53. Biofabricated Silver Nanoparticles Synergistically Activate Amphotericin B Against Mature Biofilm Forms of Candida Albicans
    Shivkrupa Devrao Halbandge, SUPRIYA PANDURANG MORTALE, Sankunny Mohan Karuppayil · 2017 · The Open Nanomedicine Journal
54. Amides Derived from Vanillic Acid: Coupling Reactions, Antimicrobial Evaluation, and Molecular Docking
    Ana Júlia de Morais Santos Oliveira, Ricardo Dias de Castro, Hilzeth de Luna Freire Pêssoa, Abdul Wadood, Damião Pergentino de Sousa · 2019 · BioMed Research International
55. Microbiota and fungal-bacterial interactions in the cystic fibrosis lung
    Eneko Santos-Fernandez, Leire Martin–Souto, Aitziber Antoran, Maialen Areitio, Leire Aparicio-Fernandez, Jean‐Philippe Bouchara, C. Schwarz, Aitor Rementerı́a, Idoia Buldain, Andoni Ramirez‐Garcia · 2023 · FEMS Microbiology Reviews
56. Development of a novel anti-biofilm peptide derived from profilin of Spodoptera frugiperda
    Amanda Carolina Borges da Silva, Janaína de Cássia Orlandi Sardi, Daniella Gorete Lourenço de Oliveira, Caio Fernando Ramalho de Oliveira, Helder Freitas dos Santos, Edson Lucas dos Santos, Edson Crusca, Marlon Henrique e Silva Cardoso, Octávio Luiz Franco, Maria Lı́gia Rodrigues Macedo · 2020 · Biofouling
57. Roles of the novel coiled-coil protein Rng10 in septum formation during fission yeast cytokinesis
    Yajun Liu, I‐Ju Lee, Mingzhai Sun, Casey A. Lower, Kurt W. Runge, Jianjie Ma, Jian‐Qiu Wu · 2016 · Molecular Biology of the Cell
58. Introductory Chapter: Fusarium: Pathogenicity, Infections, Diseases, Mycotoxins and Management
    Tülin Aşkun · 2018 · InTech eBooks
59. Inhibiting Fungal Echinocandin Resistance by Small-Molecule Disruption of Geranylgeranyltransferase Type I Activity
    Qiangqiang Sun, Kang Xiong, Yuncong Yuan, Jing Yu, Lianjuan Yang, Chao Shen, Chang Su, Yang Lü · 2019 · Antimicrobial Agents and Chemotherapy
60. Antibodies to Combat Fungal Infections: Development Strategies and Progress
    Ali Ahmed Rabaan, Amal H. Alfaraj, Amer Alshengeti, Abdulsalam Alawfi, Sara M. Alwarthan, Mashael M. Alhajri, Amal Hassan Al-Najjar, Mona A. Al Fares, Mustafa A. Najim, Souad A. Almuthree et al. · 2023 · Microorganisms
61. Antimicrobial and Antifungal Activity of Rare Substituted 1,2,3-Thiaselenazoles and Corresponding Matched Pair 1,2,3-Dithiazoles
    Tuomo Laitinen, Ilia V. Baranovsky, Lidia S. Konstantinova, Antti Poso, Oleg Alekseevich Rakitin, Christopher R. M. Asquith · 2020 · Antibiotics
62. A Host-Pathogen Interaction Screen Identifies ada2 as a Mediator of Candida glabrata Defenses Against Reactive Oxygen Species
    Kounatidis, Ilias, Ames, Lauren, Mistry, Rupal, Ho, Hsueh-lui, Haynes, Ken, Ligoxygakis, Petros · 2018 · G3 Genes Genomes Genetics
63. Overview of the Interplay Between Cell Wall Integrity Signaling Pathways and Membrane Lipid Biosynthesis in Fungi: Perspectives forAspergillus fumigatus
    João Henrique Tadini Marilhano Fabri, Marina Campos Rocha, Iran Malavazi · 2019 · Current Protein and Peptide Science
64. Cytotoxicity and Promising Anti-Biofilm of Curcuma Silver Nanoparticles against Candida albicans
    Amr A. El-Waseif, Ghada S. Abd El-Ghani, Sabah A. Abo-Elmaaty, Mervat Gameel Hassan · 2022 · Research Journal of Pharmacy and Technology
65. Investigating in vitro antifungal mechanisms of geraniol against Candida albicans
    Jiayi Zhang, Shuang Xu, Jun Tian, Zhengkun Zhou · 2025 · Archives of Microbiology
66. Candida auris : host interactions, antifungal drug resistance, and diagnostics
    Anuradha Chowdhary, Michail S. Lionakis, Neeraj Chauhan · 2025 · Microbiology and Molecular Biology Reviews
67. Investigation of in vitro Antileishmanial Activity of Moxifloxacin, Linezolid and Caspofungin on Leishmania tropica Promastigotes
    Mehmet Emin Limoncu, Bayrı Eraç, Ahmet Özbilgin, I. Cuneyt Balcioglu, Mine Hoşgör Limoncu · 2013 · Turkish Journal of Parasitology
68. Systemic Antifungal Agents
    Shmuel Shoham, Andreas H. Groll, Vidmantas Petraitis, Thomas J. Walsh · 2016 · Elsevier eBooks
69. The lipid flippase subunit Cdc50 is required for antifungal drug resistance, endocytosis, hyphal development and virulence inCandida albicans
    Dayong Xu, Xing Zhang, Biao Zhang, Xin Wu Zeng, Hongchen Mao, Haitao Xu, Linghuo Jiang, Feng Li · 2019 · FEMS Yeast Research
70. The hidden threat: Unveiling the rise of antifungal drug resistance
    Renu Chaudhary, Zoozeal Thakur · 2025 · Microbial Pathogenesis
71. Pharmacological Management of Oral and Esophageal Candidiasis: A Clinical Pharmacotherapy Perspective
    Toshinori Hirai, Masanori Nashi · 2025 · Journal of Clinical Medicine
72. Breaking down the wall: Solid-state NMR illuminates how fungi build and remodel diverse cell walls
    Isha Gautam, Ankur Ankur, Kalpana Singh, Anand Jacob, Tamara Lea Doering, Neil A. R. Gow, Jean‐Paul Latgé, Tuo Wang · 2025 · PLoS Pathogens
73. New arsenals for old armour: Biogenic nanoparticles in the battle against drug-resistant Candida albicans
    Alwar Ramanujam Padmavathi, Gangidi Kiran Kumar Reddy, P. Sriyutha Murthy, Yarlagadda Venkata Nancharaiah · 2024 · Microbial Pathogenesis
74. Navigating the fungal battlefield: cysteine-rich antifungal proteins and peptides from Eurotiales
    Jeanett Holzknecht, Florentine Marx · 2024 · Frontiers in Fungal Biology
75. Machine Learning for Antimicrobial Resistance Research and Drug Development
    Shamanth Adekhandi Shankarnarayan, Joshua D. Guthrie, Daniel A. Charlebois · 2022 · IntechOpen eBooks
76. Development of a Heat-Killed fbp1 Mutant Strain as a Therapeutic Agent To Treat Invasive Cryptococcus Infection
    Yina Wang, Keyi Wang, Amariliz Rivera, Chaoyang Xue · 2023 · Microbiology Spectrum
77. Unlocking the Therapeutic Potential of the Fungal Cell Wall: Clinical Implications and Drug Resistance
    Chibuike Ibe, Louise A. Walker, Neil A. R. Gow, Carol A. Munro · 2017 · Springer eBooks
78. Antifungal chemotherapies and immunotherapies for the future
    Darius P. H. Armstrong-James · 2022 · Parasite Immunology
79. Biomedical applications of polysaccharide-based nanocomposites from fungal origin
    Payal Gupta, Hrishikesh Gupta, Krishna Mohan Poluri · 2020 · Elsevier eBooks
80. Effects of lipopeptide biosurfactants on clinical strains of Malassezia furfur growth and biofilm formation
    Gabrielly Oliveira da Silva, Bárbara Cibelle Soares Farias, Renally Barbosa da Silva, Edson Holanda Teixeira, Rossana de Aguiar Cordeiro, Denise Cavalcante Hissa, Vânia Maria Maciel Melo · 2021 · Medical Mycology
81. Echinocandin resistance in human pathogenic fungi
    Carol A. Munro · 2012 · Expert Review of Anti-infective Therapy
82. The Toxicity of a Novel Antifungal Compound Is Modulated by Endoplasmic Reticulum-Associated Protein Degradation Components
    Shriya Raj, Karthik Krishnan, David S. Askew, Olivier Helynck, Peggy Suzanne, Aurélien Lesnard, Sylvain Rault, Ute Zeidler, Christophe d’Enfert, Jean‐Paul Latgé et al. · 2015 · Antimicrobial Agents and Chemotherapy
83. Repurposing benzimidazoles to fight Cryptococcus
    Haroldo César de Oliveira, Márcio Lourenço Rodrigues · 2021 · Fungal Biology Reviews
84. Reshaping Echinocandin Antifungal Drugs To Circumvent Glucan Synthase Point‐Mutation‐Mediated Resistance
    Moriah Jospe‐Kaufman, Efrat Ben‐Zeev, Austin Mottola, Anna Dukhovny, Judith G. Berman, Shmuel Carmeli, Micha Fridman · 2023 · Angewandte Chemie
85. Development of New Strategies for Echinocandins: Progress in Translational Research
    Thomas J. Walsh, Nkechi E. Azie, David R. Andes · 2015 · Clinical Infectious Diseases
86. Antifungal Susceptibility of Candida albicans Isolates at a Tertiary Care Hospital in Bulgaria
    Hristina Yotova Hitkova, Diana Simeonova Georgieva, Preslava Mihaylova Hristova, Mariya Sredkova · 2019 · Jundishapur Journal of Microbiology
87. Insights into the role of sphingolipids in antifungal drug resistance
    Sapna Kalra, Sunita Tanwar, Vinay Kumar Bari · 2023 · Fungal Biology Reviews
88. Mechanisms of Resistance to Antifungal Agents
    David S. Perlin · 2015 · ASM Press eBooks
89. Mechanisms of Drug Resistance in Candida albicans
    Dominique Sanglard · 2017 · Springer eBooks
90. Calcium: a central player in Cryptococcus biology
    Eamim Daidrê Squizani, Júlia Catarina Vieira Reuwsaat, Heryk Motta, Andrea Gomes Tavanti, Lívia Kmetzsch · 2021 · Fungal Biology Reviews
91. Rapamycin and caspofungin show synergistic antifungal effects in caspofungin-susceptible and caspofungin-resistant Candida strains in vitro
    Maxime Lefranc, Isabelle Accoceberry, Valérie Fitton‐Ouhabi, Nicolas Biteau, Thierry Noël · 2023 · Journal of Antimicrobial Chemotherapy
92. MK-5204: An orally active β-1,3-glucan synthesis inhibitor
    James M. Apgar, Robert R. Wilkening, Dann L. Parker, Dongfang Meng, Kenneth J. Wildonger, Donald M. Sperbeck, Mark L. Greenlee, James M. Balkovec, Amy M. Flattery, George K. Abruzzo et al. · 2020 · Bioorganic & Medicinal Chemistry Letters
93. Emerging and reemerging human fungal pathogens that affect people with weakened immune systems: a systematic review
    Amere Genet, Abayeneh Girma · 2024 · Universa Medicina
94. Genome-wide CRISPRi screen and proteomic profiling identify key genes related to ferulic acid’s antifungal activity
    Ofri Levi, Rina Zuchman, Nour Sleman, Roni Nitzan Koren, Hazem Khamaisi, Benjamin A. Horwitz · 2025 · mBio
95. Antifungal potential of Pterosiphonia complanata (Clemente) Falkenberg against Candida spp.: Chemical composition and molecular docking insights
    Bouchra Benhniya, Fatima Lakhdar, Kenzy Charles, Mohammed Salah, Noreddine Rezzoum, Leonel Pereira, Samira Etahiri · 2025 · Journal of Molecular Structure
96. Disruption to de novo uridine biosynthesis alters β-1,3-glucan masking in Candida albicans
    Mikayla M. Mangrum, Amanda K. Vogel, Andrew S. Wagner, Ainsley E. King, Jian Miao, Yue Zhou, Elise K. Phillips, Brian M. Peters, Todd B. Reynolds · 2024 · mSphere
97. 3,5-Dinitrobenzoate and 3,5-Dinitrobenzamide Derivatives: Mechanistic, Antifungal, and In Silico Studies
    Allana Brunna Sucupira Duarte, Yunierkis Pérez‐Castillo, Patrícia Néris Andrade, Ricardo Dias de Castro, Damião Pergentino de Sousa · 2022 · Journal of Chemistry
98. Antifungal activity against Candida albicans of methyl 3,5-dinitrobenzoate loaded nanoemulsion
    Allana Brunna Sucupira Duarte, Yunierkis Pérez‐Castillo, Danielle da Nóbrega Alves, Ricardo Dias de Castro, Rafael Limongi de Souza, Damião Pergentino de Sousa, Elquio Eleamen Oliveira · 2023 · Brazilian Journal of Microbiology
99. The Role of Resistance in Candida Infections: Epidemiology and Treatment
    Jack D. Sobel, Robert A. Akins · 2017 · Springer eBooks
100. Update on Antifungal Resistance and its Clinical Impact
     Brunella Posteraro, Patrizia Posteraro, Maurizio Sanguinetti · 2013 · Current Fungal Infection Reports